miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma

BACKGROUND: Despite significant advancements in multiple myeloma (MM) therapy, the highly heterogenous treatment response hinders reliable prognosis and tailored therapeutics. Herein, we have studied the clinical utility of miRNAs in ameliorating patients’ management. METHODS: miRNA-seq was performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadimitriou, Maria-Alexandra, Soureas, Konstantinos, Papanota, Aristea-Maria, Tsiakanikas, Panagiotis, Adamopoulos, Panagiotis G., Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Gavriatopoulou, Maria, Sideris, Diamantis C., Kastritis, Efstathios, Avgeris, Margaritis, Dimopoulos, Meletios-Athanasios, Terpos, Evangelos, Scorilas, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080848/
https://www.ncbi.nlm.nih.gov/pubmed/37024879
http://dx.doi.org/10.1186/s12967-023-04034-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080848/
https://www.ncbi.nlm.nih.gov/pubmed/37024879
http://dx.doi.org/10.1186/s12967-023-04034-5

Ejemplares similares